Guan Xin, Zhang Chunlei. Evaluation of efficacy of infliximab in the long-term treatment of moderate and severe psoriasis vulgaris[J].Chinese Journal of Dermatology, 2019, 52(2): 86-89.
CEM G, van der Walt JM, Ashcroft DM, et al. The global state of psoriasis disease epidemiology: a workshop report[J]. Br J Dermatol, 2017,177(1):e4⁃e7. doi: 10.1111/bjd.15610.
[2]
Carrascosa JM, Jacobs I, Petersel D, et al. Biosimilar drugs for psoriasis: principles, present, and near future[J]. Dermatol Ther (Heidelb), 2018,8(2):173⁃194. doi: 10.1007/s13555⁃018⁃0230⁃9.
[3]
Papoutsaki M, Osório F, Morais P, et al. Infliximab in psoriasis and psoriatic arthritis[J]. Bio Drugs, 2013,27 Suppl 1:13⁃23. doi: 10. 1007/BF03325638.
[4]
Yang HZ, Wang K, Jin HZ, et al. Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double⁃blind, placebo⁃controlled multicenter trial[J]. Chin Med J (Engl), 2012,125(11):1845⁃1851.
[5]
Ehrenpreis ED. Pharmacokinetic effects of antidrug antibodies occurring in healthy subjects after a single dose of intravenous infliximab[J]. Drugs R D, 2017,17(4):607⁃613. doi: 10.1007/s40268⁃017⁃0211⁃y.
[6]
Bendtzen K. Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor⁃alpha antagonists[J]. Discov Med, 2013,15(83):201⁃211.
[7]
Vincent T, Best M, Plawecki M, et al. Complete reversion of anti⁃infliximab immunization by methotrexate combination in a patient with psoriasis[J]. J Dermatol, 2015,42(10):1030⁃1031. doi: 10.1111/ 1346⁃8138.13010.
[8]
Schadler ED, Ortel B, Mehlis SL. Biologics for the primary care physician: review and treatment of psoriasis[J]. Dis Mon, 2018. pii: S0011⁃5029(18)30095⁃6. doi: 10.1016/j.disamonth.2018.06. 001.
Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment.
Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement
[J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161.